Trials / Completed
CompletedNCT00971204
Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- CardioFocus · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a demonstration of safety and efficacy of the ablation for pulmonary vein isolation in the treatment of paroxysmal atrial fibrillation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CardioFocus HeartLight Endoscopic Ablation System | PVI ablation |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2011-12-01
- Completion
- 2012-06-01
- First posted
- 2009-09-03
- Last updated
- 2016-08-01
- Results posted
- 2016-07-27
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00971204. Inclusion in this directory is not an endorsement.